"""
PharmaTabletManufactureCell — non-sterile oral solid (tablet / capsule) manufacture.

Per ADR-2605250600 §Decision 2 (Wave 1b oral tablet dosage form).

Pregel graph (5 nodes):

    receive_qc_attest             <-  pharma_qc emitted upstream (API + excipient lots)
        |
        v
    pre_blend                     ->  API + diluent + disintegrant + binder
                                      pre-blending; uniformity check
        |
        v
    granulate_or_direct_compress  ->  wet/dry granulation OR direct compression
                                      (per API flowability)
                                      drying / milling if granulation
        |
        v
    final_blend_and_compress      ->  add lubricant (mag stearate) + glidant;
                                      compression to tablet at target hardness;
                                      in-process: weight, hardness, friability,
                                      content uniformity sampling
        |
        v
    coat_and_package              ->  film-coating (HPMC + TiO₂ + opt pigment)
                                      OR uncoated;
                                      blister-pack (PVC/aluminum) or HDPE bottle
        |
        v
    emit_fill_finish_attest       ->  MST PUT com.etzhayyim.pharma.fillFinishAttestation
                                      with dosageForm = "tablet-{uncoated|film-coated|enteric}"
                                      (sterilityResult = "na", endotoxin = null,
                                       CCIT not applicable; instead dissolution /
                                       disintegration / friability / content uniformity)

Tier: B (Per-Domain).
Murakumo node (proposed): joseph (commissioning — clean room class C).
Charter Rider §2(h) risk: HIGH for API-specific label warnings:
  acetaminophen hepatotoxicity / aspirin Reye / ibuprofen GI+renal /
  diphenhydramine sedation. G11 enforcement = label content scanner downstream.
"""

from __future__ import annotations

# ─────────────────────────────────────────────────────────────────────────────
# COUNCIL ACTIVATION GATE
# ─────────────────────────────────────────────────────────────────────────────

COUNCIL_CHARTER_ATTESTATION_TX_HASH: str | None = None
SILEN_PHARMA_BASELINE_REVIEW_CID: str | None = None
QP_EQUIVALENT_REGISTRY_CID: str | None = None
TABLET_PRESS_EQUIPMENT_QUALIFICATION_CID: str | None = None
NON_STERILE_MICROBIAL_LIMIT_BASELINE_CID: str | None = None

if (
    COUNCIL_CHARTER_ATTESTATION_TX_HASH is None
    or SILEN_PHARMA_BASELINE_REVIEW_CID is None
    or QP_EQUIVALENT_REGISTRY_CID is None
    or TABLET_PRESS_EQUIPMENT_QUALIFICATION_CID is None
    or NON_STERILE_MICROBIAL_LIMIT_BASELINE_CID is None
):
    raise RuntimeError(
        "pharma_tablet_manufacture cell scaffold-only — Council has not "
        "attested (a) the yakushi master charter (G3), (b) the QP-equivalent "
        "registry (G4), (c) the tablet press equipment qualification (Wave 1b "
        "silen-pharma-review trigger), or (d) the non-sterile microbial-limit "
        "baseline per ADR-2605250600 §Decision 3. Do not deploy."
    )


# Pregel super-step skeleton:
#
# class PharmaTabletManufactureCell(PregelCell):
#     process_step = "tablet-manufacture"
#     pregel_tier = "B"
#     murakumo_node = "joseph"
#
#     def super_step(self, api_qc_attest, excipient_attests, formula_recipe):
#         # 1. validate API + excipient QC chains
#         # 2. pre-blend → granulate (wet/dry) or direct compression
#         # 3. final blend + lubricant + compression
#         # 4. in-process checks (weight / hardness / friability / CU sampling)
#         # 5. film-coating (if specified) + blistering
#         # 6. emit fillFinishAttestation with dosageForm = "tablet-*"
#         raise NotImplementedError("R2+ phase wave implements super_step")
